Diagnosis and treatment of invasive aspergillosis infection following orthotopic liver transplantation.
- Author:
Shu-hong YI
1
;
Gui-hua CHEN
;
Min-qiang LU
;
Yang YANG
;
Chang-jie CAI
;
Chi XU
;
Hua LI
;
Gen-shu WANG
;
Hui-min YI
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Amphotericin B; therapeutic use; Antifungal Agents; therapeutic use; Aspergillosis; diagnosis; drug therapy; etiology; Female; Humans; Liver Transplantation; adverse effects; Lung Diseases, Fungal; diagnosis; drug therapy; etiology; Male; Middle Aged; Neuroaspergillosis; diagnosis; drug therapy; etiology; Postoperative Complications; Retrospective Studies
- From: Chinese Journal of Surgery 2006;44(13):885-888
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the treatment and appropriate management of invasive aspergillosis infection following orthotopic liver transplantation.
METHODSThe clinical data of 576 cases who underwent orthotopic liver transplantation consecutively between January 2000 and January 2005 were analyzed retrospectively.
RESULTSThe prevalence of invasive aspergillosis infection was 1.74 (9/576), included 8 cases with pulmonary aspergillosis and 1 case with cerebral aspergillosis. The interval between transplantation and diagnosis were from 10 days to 2 months. Persistent or discontinuous low fever maybe the main clinical presentation after operation. Liposomal amphotericin B (AmBisome) is the mainly treatment for invasive aspergillosis infections, 5 patients were cured and 2 patients developed multi-organ aspergillosis infection died.
CONCLUSIONSThe clinical features of invasive aspergillosis infection following orthotopic liver transplantation were un-typical presentations in the early stage and easy to disseminate. Appropriate modification of immunosuppression therapy and early, high dose and long-term application of antifungal treatment is effective and safe to cure the disease.
